Peritoneal Dialysis Equipment Market Outlook: Growing Adoption in Developing Regions to Drive Market Growth to US$ 4.09 Billion by 2031

As per the latest market research by Business Market Insights (BMI), the research report “Peritoneal Dialysis Equipment Market Outlook Size and Forecast (2021–2031)” forecasts how the market is set to surge 51.3% by 2031 as Growing Adoption in Developing Regions Reshapes Global Peritoneal Dialysis Equipment Ecosystems. The report spotlights governments’ role in revolutionizing the global Peritoneal Dialysis Equipment landscape.

The report forecasts the market to expand from US$ 2.71 billion in 2024 to US$ 4.09 billion by 2031, registering a robust CAGR of 6.06% over the 2025–2031 period.

Governments in developing regions have taken a proactive approach to develop the peritoneal dialysis market by focusing on access, affordability, and sustainability. A major component of this will be "PD-first" or "PD-favoured" policies that will dictate that PD should be the first and preferred treatment modality for patients that are clinically appropriate to receive it. This costs of care associated with PD are lower than in-center hemodialysis (HD) because PD does not require expensive infrastructure, staff and other associated costs, which is a significant burden on public healthcare systems. The example from India, with its Pradhan Mantri National Dialysis Programme is now allowing PD reimbursement for free services for the poor. In addition, they are also investing in a bit of two-fold strategy to on how to make PD capable by developing both healthcare capacity and finally developing the supply chain logistics and networks to ensure that lists of consumable items, such as dialysate solutions, are always readily available.

Overview of report findings

Market Growth

The Peritoneal Dialysis Equipment Market is projected to grow from US$ 2.71 billion in 2024 to US$ 4.09 billion by 2031, registering a compound annual growth rate (CAGR) of 6.06% between 2025 and 2031.

The growing demand of home-based dialysis, lower cost compared to in-center hemodialysis, and government support in developing regions are key factors propelling market growth. The increasing innovation in hemodialysis solutions globally is transforming the Peritoneal Dialysis Equipment landscape.

Lower Cost Compared to In-Center HD

The significantly lower cost of peritoneal dialysis (PD) compared to in-center hemodialysis (HD) is a major driver for the PD market, particularly from the perspective of healthcare systems and payers. In-center HD necessitates substantial capital investment in dialysis centers, including specialized equipment, water purification systems, and the physical space to accommodate numerous patients simultaneously. In contrast, PD is a home-based therapy that eliminates these costly infrastructural requirements. Furthermore, HD requires a large, specialized clinical staff to be present for every treatment session, including nephrologists, nurses, and technicians, leading to high labour costs. PD, on the other hand, is managed by the patient or a caregiver at home, significantly reducing the need for clinical staff and associated labour expenses. While PD does have recurring costs for consumables like dialysate solutions, these are often outweighed by the substantial savings on facility overhead and personnel. In many regions, the total cost of PD, including supplies and periodic clinic visits, is demonstrably lower than the aggregate cost of HD, which includes not only the thrice-weekly sessions but also associated expenses like patient transportation, emergency room visits, and hospitalization for complications. This economic advantage makes PD a highly attractive option for governments and public health systems seeking to manage the growing burden of end-stage renal disease (ESRD) in a more sustainable and fiscally responsible manner.

Rising Demand for Home-Based Dialysis

The rising demand for home-based dialysis is a powerful driver for the peritoneal dialysis (PD) market. This trend is a direct response to a growing patient preference for greater autonomy, flexibility, and a better quality of life than is typically afforded by in-center hemodialysis (HD). For many patients, the rigid schedule of in-center HD—which often requires a commitment of several hours, three days a week—is a major logistical and psychological burden. This can interfere with work, education, and social activities. In contrast, home-based PD, particularly with the use of Automated Peritoneal Dialysis (APD) cyclers, allows patients to perform their therapy overnight while they sleep, freeing up their days for normal life. This shift not only improves a patient's sense of control over their health but also reduces travel time and costs associated with visiting a clinic. Furthermore, home-based PD often leads to better clinical outcomes, including a potential reduction in cardiovascular complications, fewer dietary restrictions, and less post-dialysis fatigue.

Geographic Insights

North America leads the global peritoneal dialysis (PD) market due to a combination of a well-established healthcare infrastructure, high healthcare expenditure, and a strong preference for technologically advanced home-based therapies. Favourable government initiatives and reimbursement policies, particularly in the United States, actively encourage the adoption of PD by making it a more financially viable option for both patients and healthcare providers. The region is a leader in the adoption of Automated Peritoneal Dialysis (APD), with sophisticated cyclers and remote monitoring systems that enhance patient autonomy and clinical oversight.

The Asia-Pacific (APAC) region is the fastest-growing market, driven by its immense and rapidly expanding patient population. The high and rising prevalence of diabetes and hypertension, which are the primary causes of chronic kidney disease (CKD), has created an enormous and escalating need for renal replacement therapies.

Market Segmentation

• Based on Product, the market is segmented into Automated Peritoneal Dialysis Machines, Continuous Ambulatory Peritoneal Dialysis Systems, and PD Consumables/Accessories. The PD Consumables/Accessories segment dominated the market in 2024.
• Based on Application, the market is segmented into Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis. The Continuous Ambulatory Peritoneal Dialysis segment dominated the market in 2024.

• Based on End User, the market is segmented into In-Center Dialysis Settings and Home Care Settings. The Home Care Settings dominated the market in 2024.

Competitive Strategy & Development

Key Players: The Peritoneal Dialysis Equipment Market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Fresenius Medical Care AG & Co KGaA
2. Baxter International Inc.
3. DaVita Inc.
4. Teleflex Inc
5. B. Braun SE
6. Terumo Corp

Trending Topics: Telemedicine and remote patient monitoring, Automated Peritoneal Dialysis (APD) technology, PD-first policies and favourable reimbursement, Advancements in biocompatible PD solutions and catheters, Rising demand for home-based care, Wearable artificial kidneys and other portable devices

Global Headlines

• “Medtronic and DaVita Launch Mozarc Medical- In the April 2023, Medtronic plc and DaVita Inc. announced the creation of a new, independent company, Mozarc Medical, dedicated to advancing patient-centered technology for kidney health. This new venture is focused on developing innovative solutions that improve the patient experience and expand access to care globally, particularly in the realm of home-based dialysis.”

• “Kidney Research UK Backs New Device to Help Support Better Infection Management in Peritoneal Dialysis Patients- In February 2025, Kidney Research UK has invested in the UK-based biotechnology company, MicroBioSensor, to support the development of a device designed to rapidly detect peritonitis in peritoneal dialysis fluid. This innovation aims to enable earlier detection and treatment of infections, a major concern for patients.”

Conclusion

The peritoneal dialysis (PD) equipment market is poised for robust growth, driven by a confluence of powerful factors. A primary driver is the growing demand for home-based dialysis, fuelled by patient desire for greater autonomy, flexibility, and a better quality of life compared to in-center hemodialysis (HD). This is further compounded by the lower cost of PD, which makes it a fiscally attractive and sustainable option for governments and healthcare systems, particularly in developing regions. Consequently, many governments are actively supporting market growth through "PD-first" policies and favourable reimbursement models. However, the market faces several significant restraints, including the high cost of both the dialysis treatment itself and the specialized machines, which can be prohibitive for patients without adequate insurance or government support. The high risk of peritonitis, a serious infection of the peritoneal cavity, remains a major clinical concern and can limit patient uptake. Furthermore, a limited availability of skilled healthcare professionals to train and support patients on home-based therapy is a key barrier, particularly in rural or low-resource settings. Despite these challenges, the market is rich with opportunities. Technological advancements are leading to more user-friendly and portable devices, such as wearable and smart PD cyclers with integrated telemedicine capabilities, which will enhance patient safety and adherence. The development of more biocompatible dialysate solutions is also a major trend, aimed at reducing complications and improving long-term outcomes. The ongoing focus on personalized and predictive care, enabled by data analytics, will also open new avenues for market expansion. In essence, the market's trajectory is a balance between its inherent benefits as a cost-effective and patient-centric therapy and the ongoing need to overcome clinical and logistical hurdles through continuous innovation and strategic healthcare policy.